Literature DB >> 21795298

Infrequent physician use of implantable cardioverter-defibrillators risks patient safety.

Stephen Lyman1, Art Sedrakyan, Huong Do, Renee Razzano, Alvin I Mushlin.   

Abstract

CONTEXT: Implantable cardioverter-defibrillators (ICDs) have diffused rapidly into clinical practice with little evaluation of their real-world effectiveness.
OBJECTIVES: To determine the effect of the adoption of ICD on patient safety, particularly with respect to physician volume and early outcomes.
DESIGN: Retrospective cohort of all ICD implantations in New York state from 1997 to 2006, with follow-up at 90 days and 1 year. Setting New York state non-federal hospital discharges in which an ICD was implanted during the admission. Patients were followed forward for 1 year for subsequent admissions. Patients New York state residents undergoing ICD implantation. MAIN OUTCOME MEASURES: Effects of annual and career ICD implantation volume on 90-day complication, readmission, reprogramming, mortality and revision of the ICD within 1 year.
RESULTS: This cohort (N = 38,992) represents a period of rapid adoption and implementation of this new technology, with frequency more than tripling between 1997 and 2006. We identified 6439 (16.5%) post-implantation complications and 1093 (2.8%) deaths within 90 days of implantation. The majority (73.4%) of physicians implanted one or fewer ICDs per year, and 11.0% of all implantations were performed by these very-low-volume operators. Patients treated by very-low-volume operators were more likely to die (RR = 1.8, 95% CI 1.3 to 2.4) or experience cardiac complications (RR = 4.7, 95% CI 3.3 to 6.8) even after the adjustment for case mix compared to operators who frequently performed ICD implantation.
CONCLUSIONS: These findings suggest a need for safe and effective implementation strategies for new medical technologies, which minimize patient risk due to rapid diffusion among inexperienced providers and assure that the intended benefit can be maximised rapidly.

Entities:  

Mesh:

Year:  2011        PMID: 21795298     DOI: 10.1136/hrt.2011.226282

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  5 in total

Review 1.  SAGES guidelines for the introduction of new technology and techniques.

Authors:  Dimitrios Stefanidis; Robert D Fanelli; Ray Price; William Richardson
Journal:  Surg Endosc       Date:  2014-06-18       Impact factor: 4.584

2.  Association of hospital-level volume of extracorporeal membrane oxygenation cases and mortality. Analysis of the extracorporeal life support organization registry.

Authors:  Ryan P Barbaro; Folafoluwa O Odetola; Kelley M Kidwell; Matthew L Paden; Robert H Bartlett; Matthew M Davis; Gail M Annich
Journal:  Am J Respir Crit Care Med       Date:  2015-04-15       Impact factor: 21.405

Review 3.  Adverse events following implantable cardioverter defibrillator implantation: a systematic review.

Authors:  Rebecca Persson; Amy Earley; Ann C Garlitski; Ethan M Balk; Katrin Uhlig
Journal:  J Interv Card Electrophysiol       Date:  2014-06-20       Impact factor: 1.900

4.  Epidemiology of cardiac implantable electronic device infections: incidence and risk factors.

Authors:  Hui-Chen Han; Nathaniel M Hawkins; Charles M Pearman; David H Birnie; Andrew D Krahn
Journal:  Europace       Date:  2021-06-23       Impact factor: 5.214

5.  Association of Very Low-Volume Practice With Vascular Surgery Outcomes in New York.

Authors:  Jialin Mao; Philip Goodney; Jack Cronenwett; Art Sedrakyan
Journal:  JAMA Surg       Date:  2017-08-01       Impact factor: 14.766

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.